| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:3024.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
From the Department of Cardiovascular Science and Medicine (Y.Z., W.Z., M.S., Y.Q., H.A., H.T., M.M., T.M., H.T., T.N., I.K.), Chiba University Graduate School of Medicine, Chiba; Department of Cardiovascular Medicine (N.T.), University of Tokyo Graduate School of Medicine, Tokyo; and Department of Bio-Signal Analysis, Applied Medical Engineering Science (A.N.), Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Correspondence to Issei Komuro, MD, PhD, Department of Cardiovascular Science and Medicine, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail komuro-tky{at}umin.ac.jp
Received May 28, 2003; revision received August 4, 2003; accepted August 7, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results In this study, we isolated the heat shock transcription factor 1 (HSF1) as a protective molecule by the death trap method. Cell death induced by hydrogen peroxide was prevented by overexpression of HSF1 in COS7 cells. Thermal preconditioning at 42°C for 60 minutes activated HSF1, which played a critical role in survival of cardiomyocytes from oxidative stress. In the heart of transgenic mice overexpressing a constitutively active form of HSF1, ischemia followed by reperfusion-induced ST-segment elevation in ECG was recovered faster, infarct size was smaller, and cardiomyocyte death was less than wild-type mice. Protein kinase B/Akt was more strongly activated, whereas Jun N-terminal kinase and caspase 3 were less activated in transgenic hearts than wild-type ones.
Conclusions These results suggest that HSF1 protects cardiomyocytes from death at least in part through activation of Akt and inactivation of Jun N-terminal kinase and caspase 3.
Key Words: ischemia reperfusion survival
| Introduction |
|---|
|
|
|---|
HSF1),8 we examined the role of HSF1 in the heart subjected to ischemia/reperfusion injury. | Methods |
|---|
|
|
|---|
-32P]ATP was purchased from Du Pont-New England Nuclear Co. DMEM and FBS were from GIBCO BRL Co. pCMV SPORT heart cell expression cDNA library was from Life Technologies. The enhanced chemiluminescence reaction system was from Amersham. Other reagents were from Sigma.
Cloning of Cardioprotective Genes by Death Trap Method
COS7 cells cultured in DMEM supplemented with 10% FBS were resuspended in serum-free DMEM at 2x107 cells/mL immediately before transfection. Transfection of pCMV SPORT heart cell expression cDNA library was performed by electroporation (220 V, 960 µFD) at 50 µg of plasmid cDNA per mL. Forty-eight hours later, the transfected cells were stimulated with 1 mmol/L H2O2 for 16 hours in serum-free DMEM to induce cell death and cDNA was recovered from the survived colonies. This procedure was repeated 4 times.1
Cell Preparation and DNA Transfection
Primary cultures of cardiomyocytes were prepared from ventricles of 1-day-old Wistar rats, and 0.5 to 10 µg of HSF1 cDNA per dish was transfected into COS7 cells with the 1.5 to 20 µg of green fluorescence protein (GFP)-expressing vector by the standard calcium phosphate method.9,10
HSF1 Transgenic Mice and Murine Ischemia/Reperfusion Model
Construction of the
HSF1 transgene and generation of the
HSF1 transgenic mice have been previously described.8 Ischemia/reperfusion injury was produced in 12-week-old male transgenic mice and their littermate wild-type mice by transiently ligating the left coronary artery.11 All protocols were approved by the guidelines of Chiba University.
Gel Mobility Shift Assay
DNA binding activities of HSF1 was examined as previously described using a self-complementary consensus HSE oligonucleotide (5'-CTAGAAGCTTCTAGAAGCTTCTAG-3') (Sigma) as a probe.8
Antisense Experiment
Phosphothionate antisense oligonucleotides (5'-CTAGAA- GCTTCTAGAAGCTTCTAG-3') of HSF1 or scramble oligonucleotides (5'-AGTCACGATCTATAGATCTGAGTC-3') (Sigma) were prepared and applied to the culture medium (10 µmol/L) before the thermal preconditioning treatment of cardiomyocytes.
Apoptosis Analysis
Apoptotic death of cardiomyocytes was determined by TUNEL and by DNA ladder analysis, as previously described.10,12
Western Blot Analysis
Total protein extracts from the heart or immunoprecipitates were electrophoresed on an SDS-polyacrylamide gel (SDS-PSGE) and transferred to Immobilon-p membrane (Millipore). The blotted membranes were incubated with antibodies to HSF1, HSP27, HSP70, HSP90, HSP110, caspase3, Apaf1, Akt, phospho-Akt (Ser 473), Jun N-terminal kinase (JNK), phospho-JNK (Thr 183/Tyr 185), and
-actin (Santa Cruz Biotechnology), respectively. Immunoreactivity was detected using an enhanced chemiluminescence reaction system according to the manufacturers instructions.
Statistics
Data are shown as mean±SE. Multiple group comparison was performed by one-way ANOVA followed by the Bonferroni procedure for comparison of means. A 2-tailed Student t test was used to compare transgenic with nontransgenic specimens under identical conditions. P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
To examine whether HSF1 protects cardiomyocytes against H2O2, cultured cardiomyocytes were exposed to H2O2 after thermal preconditioning at 42°C for 60 minutes followed by additional culture at 37°C for 24 hours. Electrophoretic mobility shift assay using HSF1 binding sequence revealed that the shifted band was enhanced after the thermal preconditioning (Figure 1B), indicating that HSF1 was activated in cultured cardiomyocytes by thermal preconditioning. Agarose gel electrophoresis showed that DNA ladder formation was observed in the cells treated with H2O2, whereas the DNA fragmentation was barely detectable in control cells and cells pretreated with thermal preconditioning (Figure 1C). The antisense oligonucleotides of HSF1 but not the scramble oligonucleotides abolished the protective effect of thermal preconditioning (Figure 1C), suggesting that the thermal preconditioning protects cardiomyocytes from H2O2-induced cell death through activation of HSF1.
HSF1 Transgenic Mice
To elucidate the protective role of HSF1 in the heart, we examined the transgenic mice that overexpress
HSF1.8 The transgenic mice were apparently healthy, and there were no significant differences in body weight, heart weight, blood pressure, and heart rate between the transgenic mice and littermate wild-type mice (data not shown).
Western blot analysis of heart extracts revealed that
HSF1 protein was expressed only in the adult transgenic mice, and there was no difference in expression levels of endogenous HSF1 between the transgenic and wild-type mice (data not shown).8 The expression of HSPs 27, 70, and 90 was markedly upregulated in the transgenic heart compared with wild-type heart (Figures 2A and 2B).
|
Ischemia/Reperfusion Injury
Mice were subjected to cardiac ischemia for 40 minutes followed by reperfusion for 120 minutes. There were no abnormalities in ECG before ischemia in both the transgenic mice and wild-type mice (Figure 3). When the left coronary artery was occluded, the ST-segment was rapidly elevated in both types of mice. There was no significant difference in ECG change during ischemia between the transgenic and wild-type mice. When the suture was released to allow reperfusion, the ST-segment returned to baseline within 15 minutes in the transgenic mice whereas the ST-segment elevation remained elevated over 30 minutes in wild-type mice. These results suggest that
HSF1 exerts its protective effect on the electrical activity of myocardium against ischemia/reperfusion injury.
|
We also measured areas at risk (AAR) and areas of infarction (AOI) after ischemia/reperfusion. Because we ligated the left coronary artery at the most proximal portion, the occlusion consistently created a large ischemic area (AAR, red myocardium in Figure 4A, left), and there was no difference in the ischemic area between both groups. However, there was a significant difference in infarct size (AOI, pale white areas in Figure 4A, right). Both areas of infarction/left ventricle (LV) and areas of infarction/ischemic area were significantly smaller in the transgenic group than those in the nontransgenic mice (Figure 4B).
|
Apoptosis in Mice
Ischemia/reperfusion injury has been reported to induce apoptosis in cardiomyocytes.13 Apoptotic death of cardiomyocytes was examined in the heart by TUNEL and DNA ladder analysis. Ischemia/reperfusion induced apoptosis in many cardiomyocytes (Figures 5A and 5B) and produced marked DNA ladder formation (Figure 5C) in the ischemic area of wild-type heart. The number of apoptotic cells and the DNA fragmentation were significantly less in the
HSF1 transgenic heart than the wild-type one (Figures 5A, 5B, and 5C). Caspase 3 was activated and Apaf1-cytochrome C complex was significantly increased in wild-type mice but less in the transgenic mice after ischemia/reperfusion (Figure 5D). Instead, more Apaf1-HSP70 association was observed in the transgenic heart than in the wild-type heart after ischemia/reperfusion (Figure 5D).
|
Activation of Protein Kinases
It has been reported that many stresses, including ischemia/reperfusion, activate several protein kinases, including Akt/protein kinase B and JNK,14 and that activation of Akt induces survival of cells whereas activation of JNK usually triggers death-signaling pathways. In the basal state, there was no difference in the activity of Akt and JNK between the wild-type and the transgenic heart (Figures 6A through 6C). Ischemia/reperfusion induced a significant activation of Akt and JNK in the wild-type heart (Figures 6A through 6C), suggesting that both survival and death signaling were activated in response to ischemia/reperfusion. In the transgenic heart, activation of Akt in response to ischemia/reperfusion was more prominent whereas activation of JNK was weaker than in the wild-type heart (Figures 6A through 6C). Although there was no change in protein levels of Akt and JNK after ischemia/reperfusion (Figure 6A), the amount of Akt and JNK that bound to HSP90 and HSP70, respectively, was more markedly increased in the transgenic heart compared with the wild-type heart after ischemia/reperfusion (Figures 7A through 7C).
|
|
| Discussion |
|---|
|
|
|---|
HSF1 compared with wild-type mice. Although HSP70 has been reported to have a cardioprotective function,1517 the role of other HSPs in the heart is largely unknown. The
HSF1 transgenic mouse provides a good model to examine the role of activated HSF1 and of multiple HSPs in the heart. Hearts of the transgenic mice were more resistant to ischemia/reperfusion injury, as indicated by faster recovery of ST-segment elevation in ECG and smaller infarct size. There are several potential mechanisms underlying the cardioprotective effect of HSPs.4,5 HSPs are generally believed to help the correct folding of many proteins and restore their functional structures or target denatured proteins to the lysosome for degradation as molecular chaperones.4,5 These functions of HSPs as molecular chaperones play important roles in maintaining the normal cell functions and promoting cell survival. Functions of HSPs other than molecular chaperones have recently attracted much attention in many organs, including the heart. It has been reported that accumulation of HSPs in myocardium shows an ATP-sparing effect that enhances preservation of high-energy phosphates.4,5 Repeated coronary occlusions, called ischemic preconditioning, have been reported to induce rapid normalization of the elevated ST-segment during reperfusion by improving regional acidosis and hypokalemia.18 HSPs may be involved in the faster normalization of ST-segment after reperfusion through restoration of the metabolic and ionic balance.
We showed here that ischemia/reperfusion induced less apoptosis of cardiomyocytes in the
HSF1 transgenic mice than wild-type mice. Apoptosis is induced by defined biochemical mechanisms, including release of cytochrome C from mitochondria to cytoplasm and activation of Apaf1 through forming an apoptosome complex.19,20 The apoptosome complexes cleave and activate caspase 3, leading to the inevitable fate of cell death. It has been reported that overexpression of caspase 3 in the heart significantly increases infarct size21 and that the treatment with a caspase inhibitor conversely reduces infarct size.22 HSPs have been reported to inhibit the formation of the apoptosome complexes through forming cytosolic complexes with Apaf1 or cytochrome C and then inhibit activation of caspases.19,20 In this study, Apaf1 formed more complexes with HSP70 and less with cytochrome C in the transgenic heart than the wild-type one, and ischemia/reperfusion activated Apaf1 and caspase 3 more weakly in the transgenic heart than the wild-type one. These results and observations suggest that HSPs protect cardiomyocytes from ischemia/reperfusion-induced cell death at least in part through forming complexes with Apaf1 and inhibiting the activation of caspase 3.
Both Akt and JNK were activated in the heart after ischemia/reperfusion, as reported previously.23,24 Activation of Akt has been reported to protect cardiomyocytes against various stresses, such as oxidative stress25 and the ischemia/reperfusion injury,26 whereas JNK has been indicated to induce apoptosis during ischemia/reoxygenation in rat cardiomyocytes.27 In the present study, ischemia/reperfusion activated more Akt and less JNK in the transgenic heart than the wild-type one. HSP90 has been reported to bind to Akt and promote activation of Akt through inhibition of protein phosphatase 2A.28 Another recent report also showed that overexpression of HSP90 leads to an increased phosphorylation of Akt.29 On the other hand, Hsp70 family can suppress stress-activated signaling by directly binding to JNK.14,30 We here observed that association between both HSP90 and Akt and HSP70 and JNK was more enhanced in the HSF1 transgenic heart than in the wild-type heart. These results collectively suggest that HSPs exert cardioprotective effects through activation of Akt and suppression of JNK. Additional study is needed to elucidate which mechanism plays a major role in HSF1/HSP-induced protection of cardiomyocytes.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res. 1998; 83: 117132.
3. Pirkkala L, Nykanen P, Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 2001; 15: 11181131.
4. Gray CC, Amrani M, Yacoub MH. Heat stress proteins and myocardial protection: experimental model or potential clinical tool? Int J Biochem Cell Biol. 1999; 31: 559573.[CrossRef][Medline] [Order article via Infotrieve]
5. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res. 2001; 51: 637646.
6. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation. 2002; 105: 10121017.
7. Knowlton AA, Sun L. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol. 2001; 280: H455H464.
8. Nakai A, Suzuki M, Tanabe M. Arrest of spermatogenesis in mice expressing an active heat shock transcription factor 1. EMBO J. 2000; 19: 15451554.[CrossRef][Medline] [Order article via Infotrieve]
9. Zou Y, Komuro I, Yamazaki T, et al. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ Res. 1998; 82: 337345.
10. Zhu W, Shiojima I, Hiroi Y, et al. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J Biol Chem. 2000; 275: 3529135296.
11. Harada K, Komuro I, Hayashi D, et al. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation. 1998; 97: 315317.
12. Gu Y, Zou Y, Aikawa R, et al. Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol Cell Biochem. 2001; 223: 3546.[CrossRef][Medline] [Order article via Infotrieve]
13. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996; 79: 949956.
14. Gabai VL, Sherman MY. Interplay between molecular chaperones and signaling pathways in survival of heat shock. J Appl Physiol. 2002; 92: 17431748.
15. Plumier JC, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest. 1995; 95: 18541860.[Medline] [Order article via Infotrieve]
16. Marber MS, Mestril R, Chi SH, et al. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest. 1995; 95: 14461456.[Medline] [Order article via Infotrieve]
17. Radford NB, Fina M, Benjamin IJ, et al. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci U S A. 1996; 93: 23392342.
18. Figueras J, Segura R, Bermejo B. Repeated 15-minute coronary occlusions in pigs increase occlusion arrhythmias but decrease reperfusion arrhythmias that are associated with extracellular hypokalemia. J Am Coll Cardiol. 1996; 28: 15891597.[Abstract]
19. Saleh A, Srinivasula SM, Balkir L, et al. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2000; 2: 476483.[CrossRef][Medline] [Order article via Infotrieve]
20. Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000; 19: 43104322.[CrossRef][Medline] [Order article via Infotrieve]
21. Condorelli G, Roncarati R, Ross JJ, et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci U S A. 2001; 98: 99779982.
22. Okamura T, Miura T, Takemura G, et al. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res. 2000; 45: 642650.
23. Mockridge JW, Marber MS, Heads RJ. Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes. Biochem Biophys Res Commun. 2000; 270: 947952.[CrossRef][Medline] [Order article via Infotrieve]
24. He H, Li HL, Lin A, et al. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia. Cell Death Differ. 1999; 6: 987991.[CrossRef][Medline] [Order article via Infotrieve]
25. Pham FH, Sugden PH, Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res. 2000; 86: 12521258.
26. Matsui T, Tao J, del MF, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001; 104: 330335.
27. Hreniuk D, Garay M, Gaarde W, et al. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol. 2001; 59: 867874.
28. Sato S, Fujita N, Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A. 2000; 97: 1083210837.
29. Brouet A, Sonveaux P, Dessy C, et al. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res. 2001; 89: 866873.
30. Park HS, Lee JS, Huh SH, et al. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 2001; 20: 446456.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. E. Mortensen, L. N. Conley, J. Hedegaard, T. Kalstad, P. Sorensen, C. Bendixen, and A. Revhaug Regenerative response in the pig liver remnant varies with the degree of resection and rise in portal pressure Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G819 - G830. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takaki, M. Fujimoto, T. Nakahari, S. Yonemura, Y. Miyata, N. Hayashida, K. Yamamoto, R. B. Vallee, T. Mikuriya, K. Sugahara, et al. Heat Shock Transcription Factor 1 Is Required for Maintenance of Ciliary Beating in Mice J. Biol. Chem., December 21, 2007; 282(51): 37285 - 37292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, W. Campbell, and R. S. Vander Heide Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H638 - H647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khan, S. Varadharaj, L. P. Ganesan, J. C. Shobha, M. U. Naidu, N. L. Parinandi, S. Tridandapani, V. K. Kutala, and P. Kuppusamy C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2136 - H2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang, Z. Xu, X.-R. He, L. H. Michael, and C. Patterson CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2836 - H2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yin, L. Chao, and J. Chao Kallikrein/Kinin Protects against Myocardial Apoptosis after Ischemia/Reperfusion via Akt-Glycogen Synthase Kinase-3 and Akt-Bad{middle dot}14-3-3 Signaling Pathways J. Biol. Chem., March 4, 2005; 280(9): 8022 - 8030. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SoRelle Cardiovascular News Circulation, December 16, 2003; 108 (24): e9079 - e9080. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |